Ethane;molecular hydrogen;4-[(6-piperazin-1-yl-3-pyridinyl)oxy]butan-1-amine;hydroiodide
C15H31IN4O — CID 142368224
Data last refreshed: (MolForge compound catalog, from PubChem)
About Ethane;molecular hydrogen;4-[(6-piperazin-1-yl-3-pyridinyl)oxy]butan-1-amine;hydroiodide
Ethane;molecular hydrogen;4-[(6-piperazin-1-yl-3-pyridinyl)oxy]butan-1-amine;hydroiodide (PubChem CID 142368224) has the molecular formula C15H31IN4O and a molecular weight of 410.34 g/mol. Its IUPAC name is ethane;molecular hydrogen;4-[(6-piperazin-1-yl-3-pyridinyl)oxy]butan-1-amine;hydroiodide.
Molecular Properties
| Compound Name | Ethane;molecular hydrogen;4-[(6-piperazin-1-yl-3-pyridinyl)oxy]butan-1-amine;hydroiodide |
|---|---|
| PubChem CID | 142368224 |
| Molecular Formula | C15H31IN4O |
| Molecular Weight | 410.34 g/mol |
| Exact Mass | 410.15 |
| IUPAC Name | ethane;molecular hydrogen;4-[(6-piperazin-1-yl-3-pyridinyl)oxy]butan-1-amine;hydroiodide |
| SMILES | CC.I.NCCCCOc1ccc(N2CCNCC2)nc1.[H][H] |
| InChI | InChI=1S/C13H22N4O.C2H6.HI.H2/c14-5-1-2-10-18-12-3-4-13(16-11-12)17-8-6-15-7-9-17;1-2;;/h3-4,11,15H,1-2,5-10,14H2;1-2H3;2*1H |
| InChIKey | DCWSRLXSACHGOB-UHFFFAOYSA-N |
| XLogP | 2.50 |
| TPSA | 63.41 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 410.34 |
| LogP ≤ 5 | 2.50 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142368224 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.